L
Laboratorios Richmond SACIF
BCBA:RICH
Laboratorios Richmond SACIF
BCBA:RICH
Price:
1 870
ARS
-5.08%
Market Closed
Market Cap:
151B
ARS
Balance Sheet
Balance Sheet Decomposition
Laboratorios Richmond SACIF
Laboratorios Richmond SACIF
Balance Sheet Decomposition is not available for
Laboratorios Richmond SACIF
Laboratorios Richmond SACIF
Balance Sheet
Laboratorios Richmond SACIF
Laboratorios Richmond SACIF
Currency: ARS
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
3
|
1
|
5
|
16
|
16
|
794
|
771
|
296
|
774
|
9 091
|
1 256
|
603
|
1 512
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
217
|
296
|
370
|
359
|
444
|
603
|
1 512
|
|
| Cash Equivalents |
3
|
1
|
5
|
16
|
16
|
794
|
554
|
0
|
403
|
8 731
|
812
|
0
|
0
|
|
| Short-Term Investments |
4
|
2
|
2
|
1
|
8
|
4
|
1
|
2
|
427
|
13 978
|
2 246
|
220
|
8 454
|
|
| Total Receivables |
92
|
112
|
193
|
272
|
513
|
759
|
1 208
|
2 668
|
4 503
|
7 815
|
5 796
|
13 869
|
32 382
|
|
| Accounts Receivables |
86
|
99
|
178
|
258
|
488
|
657
|
1 048
|
2 539
|
4 310
|
6 881
|
4 756
|
11 275
|
28 170
|
|
| Other Receivables |
6
|
13
|
14
|
13
|
25
|
103
|
160
|
129
|
193
|
934
|
1 041
|
2 594
|
4 211
|
|
| Inventory |
64
|
83
|
95
|
142
|
190
|
476
|
816
|
1 267
|
2 861
|
7 914
|
5 554
|
16 706
|
26 272
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
231
|
243
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
162
|
197
|
293
|
431
|
727
|
2 033
|
3 026
|
4 476
|
8 160
|
30 066
|
14 040
|
31 398
|
68 618
|
|
| PP&E Net |
51
|
53
|
55
|
55
|
58
|
270
|
591
|
1 629
|
3 041
|
15 537
|
21 794
|
101 002
|
158 539
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
591
|
1 629
|
3 041
|
15 537
|
21 794
|
101 002
|
158 539
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
490
|
764
|
1 383
|
3 042
|
3 289
|
11 009
|
25 520
|
|
| Intangible Assets |
6
|
7
|
8
|
8
|
18
|
61
|
220
|
457
|
990
|
2 850
|
3 336
|
12 747
|
26 079
|
|
| Goodwill |
40
|
31
|
30
|
31
|
31
|
145
|
221
|
335
|
551
|
1 035
|
1 017
|
2 749
|
4 159
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
6
|
10
|
109
|
554
|
679
|
|
| Long-Term Investments |
3
|
0
|
1
|
0
|
24
|
67
|
18
|
6
|
29
|
284
|
226
|
1 171
|
1 170
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
8
|
3
|
0
|
82
|
84
|
159
|
267
|
198
|
5 283
|
909
|
|
| Other Assets |
40
|
31
|
30
|
31
|
31
|
145
|
221
|
335
|
551
|
1 035
|
1 017
|
2 749
|
4 159
|
|
| Total Assets |
261
N/A
|
287
+10%
|
386
+34%
|
533
+38%
|
861
+62%
|
2 577
+199%
|
4 161
+61%
|
6 990
+68%
|
12 937
+85%
|
50 048
+287%
|
40 720
-19%
|
154 904
+280%
|
260 153
+68%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
63
|
56
|
103
|
162
|
225
|
554
|
1 319
|
2 534
|
3 563
|
11 151
|
4 787
|
23 759
|
28 553
|
|
| Accrued Liabilities |
4
|
4
|
7
|
7
|
11
|
43
|
47
|
61
|
150
|
351
|
475
|
1 749
|
6 437
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
300
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
45
|
86
|
118
|
140
|
207
|
402
|
501
|
514
|
830
|
3 557
|
2 911
|
9 666
|
18 575
|
|
| Other Current Liabilities |
11
|
8
|
13
|
29
|
104
|
90
|
56
|
246
|
517
|
3 108
|
861
|
1 133
|
3 271
|
|
| Total Current Liabilities |
123
|
154
|
240
|
338
|
547
|
1 090
|
1 923
|
3 356
|
5 359
|
18 167
|
9 034
|
36 306
|
56 835
|
|
| Long-Term Debt |
22
|
16
|
10
|
33
|
23
|
38
|
148
|
264
|
1 481
|
18 814
|
18 539
|
84 487
|
125 038
|
|
| Deferred Income Tax |
0
|
2
|
3
|
0
|
0
|
64
|
229
|
363
|
649
|
2 573
|
2 902
|
11 077
|
12 869
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
92
|
68
|
100
|
160
|
127
|
403
|
1 051
|
|
| Other Liabilities |
24
|
25
|
40
|
66
|
101
|
133
|
152
|
148
|
246
|
24
|
28
|
81
|
62
|
|
| Total Liabilities |
169
N/A
|
196
+16%
|
293
+49%
|
437
+49%
|
672
+54%
|
1 324
+97%
|
2 544
+92%
|
4 199
+65%
|
7 834
+87%
|
39 737
+407%
|
30 630
-23%
|
132 354
+332%
|
195 855
+48%
|
|
| Equity | ||||||||||||||
| Common Stock |
67
|
67
|
67
|
67
|
67
|
369
|
568
|
774
|
1 168
|
2 275
|
2 275
|
7 085
|
15 428
|
|
| Retained Earnings |
25
|
25
|
26
|
30
|
123
|
158
|
110
|
450
|
1 562
|
3 776
|
3 777
|
1 487
|
16 754
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
726
|
1 117
|
1 520
|
2 295
|
4 470
|
4 470
|
13 920
|
30 313
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 963
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
42
|
47
|
78
|
209
|
432
|
58
|
3 159
|
|
| Total Equity |
92
N/A
|
91
-1%
|
93
+2%
|
96
+3%
|
189
+97%
|
1 253
+561%
|
1 617
+29%
|
2 791
+73%
|
5 103
+83%
|
10 312
+102%
|
10 090
-2%
|
22 549
+123%
|
64 298
+185%
|
|
| Total Liabilities & Equity |
261
N/A
|
287
+10%
|
386
+34%
|
533
+38%
|
861
+62%
|
2 577
+199%
|
4 161
+61%
|
6 990
+68%
|
12 937
+85%
|
50 048
+287%
|
40 720
-19%
|
154 904
+280%
|
260 153
+68%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
19
|
67
|
67
|
67
|
67
|
81
|
81
|
81
|
81
|
81
|
81
|
81
|
81
|
|
Switch to:
Switch to:
See Also
Discover More
